USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lansus Technologies Inc.

USPTO PatentsView assignee record - 14 granted patents across 11 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H03F (Amplifiers).

RSS updates for this company

The verdict

According to USPTO PatentsView, Lansus ranks #20,001 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 11 technology areas.

#20,001
of 49,997 US assignees by volume
Top 18%
by Innovation Score (47.9/100)
11.4
avg claims per patent
+40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20001 · Foreign Corporation #20,001 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,001/49,997
  • PHOTO-FINISH Krystal Biotech
  • CPC-FOCUS H03F · 11 areas
  • INNOV-PAR 47.9/100
  • CLAIMS-PAR 11.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +40% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Krystal Biotech, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lansus’s 47.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Lansus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Lansus's Innovation Score is 47.9/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Lansus?

Each dot is one of Lansus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lansus’s own 11.4 claims/patent is at or below the 13.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Lansus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 510152025 Granted patents (volume) Avg claims / patent Krystal Biotech, Inc. - 14, 23.07Krystal BiotechKurtz GmbH - 14, 17.43KurtzL.E. Jones Company - 14, 15.86L E JonesLandauer, Inc. - 14, 19.93LandauerLeauto Intelligent Technology (BEIJING) Co. Ltd. - 14, 7.57Leauto Intelligen…LES Produits Sunforce Inc. - 14, 6.29LES Produits Sunf…LIA Diagnostics, Inc. - 14, 7.79LIA DiagnosticsLiebherr-elektronik GMBH - 14, 13.14Liebherr-elektron…Lansus Technologies Inc. - 14, 11.36Lansus
Lansus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lansus's grants concentrate

Lansus Technologies Inc. is a focused PatentsView assignee: 11 CPC subclasses with 78.6% of grants classified under H03F (Amplifiers). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2017. By volume, Lansus sits between Krystal Biotech, Inc. and Liebherr-elektronik GMBH.

Lansus's three-year grant acceleration

Lansus Technologies Inc. shows 6 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Lansus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Lansus holds 14 patents at rank #19,998, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Lansus

By rank, the assignees closest to #19,998 in granted patent volume.

Leaders in H03F (Amplifiers)

Other assignees with the most granted patents in Lansus's primary technology class.

Lansus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201720182021202320242025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Lansus Technologies Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 7.1%
2018 4 28.6%
2021 1 7.1%
2023 5 35.7%
2024 1 7.1%
2025partial year 2 14.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Lansus Technologies Inc.'s patent record in context - here's where to go next.

  • Lansus Technologies Inc.'s lead technology class is H03F (Amplifiers), 78.6% of its portfolio - see every assignee active in that class. Explore H03F
  • Ranked #20,001 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Lansus Technologies Inc. against Krystal Biotech, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.